ArticleJournal of pharmacy & bioallied sciences2025
Evaluation of Role and Efficacy of Autologous Platelet-Rich Plasma Injection Treatment for Hair Loss: A Prospective Clinical Trial.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Promises and Pitfalls of Regenerative Therapies for Androgenetic Alopecia: Platelet-Rich Plasma, Photobiomodulation, Stem Cells, and Exosomes.Medical sciences (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The purpose of this study is to assess the efficacy and safety of autologous platelet-rich plasma injections in male and female patients with androgenetic alopecia. Method: A prospective clinical study on 5 patients with moderate to severe alopecia involving PRP preparation from patients' own blood using the double-spin method that was subsequently injected three times at 4-week intervals. Hair follicle assessment was performed based on the pull test, macroscopic camera pictures, biopsy, and patient surveys: during baseline and 3-week, 6-week, and 3-month follow-up visits. Results: After the third PRP injection, all patients displayed a considerable improvement in follicle density and a drop in hair loss. At six weeks, hair follicle density rose from baseline to 38.6 ± 7.6 at 3 months. Moreover, hair follicle thickness increased. In the satisfaction survey, scores improved with an average of 8.2 over a ten-week period. There were no major side consequences. Conclusion: Autologous PRP injection is a safe and effective procedure that significantly improves hair density and patient satisfaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.